TIA
GSK icon

Tiemann Investment Advisors’s GSK GSK Stock Holding History

Tiemann Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,872
Closed -$259K – 143
2014
Q2 		$259K Buy
3,872
+560
+17% +$37.9K 0.29% 114
2014
Q1 		$221K Buy
+3,312
New +$224K 0.25% 128

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tiemann Investment Advisors's GSK Position: Q3 2014 in Review

Tiemann Investment Advisors sold out of GSK (GSK) in Q3 2014, closing a stake of 3,872 shares — an estimated $259K sold.

Tiemann Investment Advisors first reported a position in GSK in Q1 2014 and held it in 2 quarters. The position peaked at $259K in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

  • Tiemann Investment Advisors reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
  • Tiemann Investment Advisors sold 3,872 GSK shares in Q3 2014, an estimated $259K.
  • Tiemann Investment Advisors first reported a position in GSK in Q1 2014 and held it in 2 quarters.
  • Tiemann Investment Advisors's GSK position peaked at $259K in Q2 2014.
  • 701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Tiemann Investment Advisors's 13F filing for Q3 2014, filed 28 Oct 2014.